लोड हो रहा है...
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
The use of engineered T cells in adoptive transfer therapies has shown significant promise in treating hematological cancers. However, successes treating solid tumors are much less prevalent. Oncolytic viruses (OVs) have the capacity to induce specific lysis of tumor cells and indirectly impact tumo...
में बचाया:
में प्रकाशित: | Mol Ther Oncolytics |
---|---|
मुख्य लेखकों: | , , , , |
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Nature Publishing Group
2015
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782951/ https://ncbi.nlm.nih.gov/pubmed/27119109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.14 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|